| 2010-08-01 |
Novel Antibodies & Therapeutic Proteins: Technology Challenges & Future Prospects |
PharmaVision |
| 2010-07-01 |
Competitor Analysis: Antibody-Drug Conjugates (ADC) |
La Merie S.L. |
| 2010-07-01 |
Competitor Analysis: Anti-Infective Antibodies |
La Merie S.L. |
| 2010-07-01 |
Therapeutic Monoclonal Antibody Production |
CHI Insight Pharma Reports |
| 2010-06-24 |
Triple Analysis: Prostate Cancer, Antibodies and Peptides |
BioSeeker Group AB |
| 2010-06-24 |
Triple Analysis: Cancer Vaccines, Antibodies and Peptides |
BioSeeker Group AB |
| 2010-06-14 |
Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025 |
Visiongain |
| 2010-06-01 |
Competitor Analysis: P. aeruginosa Vaccines and Therapeutics |
La Merie S.L. |
| 2010-06-01 |
Therapeutic Drug Monitoring: US, Europe, Japan
Test Volume and Sales Forecasts by Country and Market Segment |
Venture Planning Group |
| 2010-06-01 |
CEA Testing Market: US, Europe, Japan-Test Volume, Sales Forecasts and Supplier Shares by Country |
Venture Planning Group |
| 2010-06-01 |
PSA: US, Europe, Japan-Test Volume, Sales Forecasts and Supplier Shares by Country |
Venture Planning Group |
| 2010-06-01 |
D-Dimer: US, Europe, Japan-Test Volume Forecasts by Country and Market Segment |
Venture Planning Group |
| 2010-05-24 |
Triple Analysis: Lymphoma, Prostate Cancer and Antibodies |
BioSeeker Group AB |
| 2010-05-01 |
Biotechnologies for Medical Applications: Global Markets |
BCC Research |
| 2010-04-28 |
Special Report: Can New Therapies Unseat Traditional Chemotherapy Regimens in Acute Myelogenous Leukemia? |
Decision Resources |
| 2010-04-26 |
Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change is Around the Corner in a Highly Competitive Market Place |
BioSeeker Group AB |
| 2009-11-02 |
Monoclonal antibodies: 2009 update |
Datamonitor |
| 2009-07-01 |
Competitor Analysis: Immunotoxins |
La Merie S.L. |
| 2009-06-26 |
Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV) |
Espicom Healthcare Intelligence |
| 2009-06-01 |
Competitor Analysis: Antibody-Drug Conjugates (ADC) |
La Merie S.L. |
